GGrantIndex
← Leaderboards

Thomas G Blanchard

National Disease Research Interchange

$4,588,839
Attributed
$13,397,472
Total exposure
5
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3.5M · FY200525
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$13,397,472 · 5

By mechanism

U24$10,570,360 · 1
U19$1,285,150 · 1
R01$1,054,976 · 1
R56$262,500 · 1
UH2$224,486 · 1

Top collaborators

Others in their field

Top investigators on “Cells

Research focus

CellsImmune ResponseImmunityDesignIn VitroResponseImmunologicsBacteriaGastric MucosaInflammationLaboratoriesHelicobacter PyloriHelicobacter InfectionsHistologicLeadEvaluationInflammatoryAnimalsDiagnosisInfectionChildGastrointestinal Tract StructureMucous MembraneOral

Grant awards (18)

Pediatric Biospecimen Procurement Center (BPC) Supporting the Developmental Gene Expression (dGTEx) Project$1,357,016
U24 · FY2025 · HD
Pediatric Biospecimen Procurement Center (BPC) Supporting the Developmental Gene Expression (dGTEx) Project$2,343,364
U24 · FY2024 · HD
Pediatric Biospecimen Procurement Center (BPC) Supporting the Developmental Gene Expression (dGTEx) Project$3,519,980
U24 · FY2022 · HD
Pediatric Biospecimen Procurement Center (BPC) Supporting the Developmental Gene Expression (dGTEx) Project$3,350,000
U24 · FY2021 · HD
Prenatal alcohol effects on the gut microbiome contributing to failure to thrive and altered immune function$112,243
UH2 · FY2018 · AA · contact PI
Prenatal alcohol effects on the gut microbiome contributing to failure to thrive and altered immune function$112,243
UH2 · FY2017 · AA · contact PI
Peptide Conformation Constrainment Technology and Novel Mucosal Adjuvants to$204,008
U19 · FY2013 · AI · contact PI
Peptide Conformation Constrainment Technology and Novel Mucosal Adjuvants to$226,018
U19 · FY2012 · AI · contact PI
Peptide Conformation Constrainment Technology and Novel Mucosal Adjuvants to$275,359
U19 · FY2011 · AI · contact PI
Peptide Conformation Constrainment Technology and Novel Mucosal Adjuvants to$276,501
U19 · FY2010 · AI · contact PI
Helicobacter Pylori-Specific Regulatory T Cells that Limit the Host Response$262,500
R56 · FY2010 · AI · contact PI
Peptide Conformation Constrainment Technology and Novel Mucosal Adjuvants to$303,264
U19 · FY2009 · AI · contact PI
H. PYLORI-SPECIFIC REGULATORY T CELLS THAT LIMIT HOST RESPONSE$177,589
R01 · FY2008 · AI · contact PI
H. PYLORI-SPECIFIC REGULATORY T CELLS THAT LIMIT HOST RESPONSE$195,038
R01 · FY2007 · AI · contact PI
H. PYLORI-SPECIFIC REGULATORY T CELLS THAT LIMIT HOST RESPONSE$8,172
R01 · FY2007 · AI · contact PI
H. PYLORI-SPECIFIC REGULATORY T CELLS THAT LIMIT HOST RESPONSE$221,177
R01 · FY2006 · AI · contact PI
H. PYLORI-SPECIFIC REGULATORY T CELLS THAT LIMIT HOST RESPONSE$226,500
R01 · FY2005 · AI
H. PYLORI- REGULATORY T CELLS THAT LIMIT HOST RESPONSE$226,500
R01 · FY2004 · AI